Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
Volatopnee
1 other identifier
interventional
41
1 country
1
Brief Summary
The dyspnea is a common symptom in patients with many respiratory diseases particularly chronic obstructive airway diseases, but also cardiovascular pathologies, obesity, or also in the deconditioned healthy subjects. Called volatolom corresponds to the set of volatile organic compounds (VOCs) contained in exhaled air. The analysis of volatolom can be done either by the methods based on mass spectrometry which allows the identification of each VOC in the exhaled air or by the use of electronic noses which are more simple to use, less specific and produce a quantitive signal change based on pattern recognition algorithms providing a global profile of the VOC without identifying them. The aim of the study is to determine whether the analysis of VOCs in exhaled air would identify biomarkers related to the intensity and type of experimental dyspnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
June 5, 2020
CompletedStudy Start
First participant enrolled
September 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 14, 2020
CompletedOctober 22, 2020
October 1, 2020
1 month
February 12, 2020
October 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of variation of volatile organic compounds profiles in exhaled air during dyspnea and normal breathing.
Comparison of variation in VOC profiles in exhaled air of healthy subjects, over 2 types of dyspnea (inspiratory load and breath holding) relative to VOC profiles during normal rest ventilation. The VOC will be identified by their molecular mass (by the mass spectrometry) and the variations in the sensors properties of the electronic noses producing a quantitive signal change based on pattern recognition algorithms.
at the only one study visit: around 2 hours
Secondary Outcomes (4)
Comparison of variation of volatile organic compounds profiles in exhaled air between the 2 types of dyspnea.
at the only one study visit: around 2 hours
Correlation between the intensity of the affective component of the dyspnea and the variation of VOC profiles.
at the only one study visit: around 2 hours
Correlation between the intensity of the sensory components of the dyspnea and the variation of VOC profiles.
at the only one study visit: around 2 hours
Comparison of VOC profiles in exhaled air according to smoking status.
at the only one study visit: around 2 hours
Study Arms (2)
A - load/apnea
EXPERIMENTALThreshold inspiratory load then apnea
B- apnea/load
EXPERIMENTALapnea than threshold inspiratory load
Interventions
using an electronic nose and a mass spectrometry
Eligibility Criteria
You may qualify if:
- healthy subject
- no dyspnea
- non smoking or daily smoking more than 5 years packs
- perfect knowing of the French language
- the consent form signed
- affiliated to a health insurance plan
You may not qualify if:
- chronic disease
- history of asthma or Chronic obstructive pulmonary disease (COPD)
- personal or family atopy
- cannabis use
- electronic cigarette
- medication except contraception
- pregnant woman
- without liberty or guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital Fochlead
Study Sites (1)
Foch hospital
Suresnes, 92151, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe Devillier
Hopital Foch
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2020
First Posted
June 5, 2020
Study Start
September 7, 2020
Primary Completion
October 14, 2020
Study Completion
October 14, 2020
Last Updated
October 22, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share